FDA Inspection
Rocket Pharmaceuticals, Inc.Rocket Pharmaceuticals, Inc. – FDA Inspection, Jan 25, 2024
Record Details
This FDA Inspection record concerns Rocket Pharmaceuticals, Inc., with an inspection on January 25, 2024, issued by the Center for Biologics Evaluation and Research.
- Company
- Rocket Pharmaceuticals, Inc.
- Inspection Date
- January 25, 2024
View Company Profile
ID · 74ae407a-5368-4670-9478-2613efcf844a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1227760
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.53(c)(1)Investigator statement (FDA 1572)
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.